RNA Interference Targeting Connective Tissue Growth Factor Inhibits the Transforming Growth Factor-β2Induced Proliferation in Human Tenon Capsule Fibroblasts
Author(s) -
Jiaona Jing,
Ping Li,
Tiejun Li,
Yuncheng Sun,
Huaijin Guan
Publication year - 2013
Publication title -
journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.818
H-Index - 40
eISSN - 2090-0058
pISSN - 2090-004X
DOI - 10.1155/2013/354798
Subject(s) - medicine , capsule , connective tissue , transforming growth factor , growth factor , rna interference , mortise and tenon , rna , interference (communication) , microbiology and biotechnology , cancer research , pathology , genetics , biology , gene , telecommunications , receptor , channel (broadcasting) , botany , structural engineering , computer science , engineering
Purpose . This study was to determine the effect of CTGF-small interfering RNA (siRNA) on TGF- β 2 -induced proliferation in human Tenon capsule fibroblasts (HTFs). Methods . HTFs were transfected with four of CTGF-siRNAs separately for screening of gene silencing efficacy that was determined by transcript level measured by quantitative real-time PCR (qRT-PCR). Recombinant TGF- β 2 was added into the culture to stimulate the proliferation of HTFs. The gene silencing efficacy of the siRNAs was evaluated by qRT-PCR and immunofluorescence of CTGF transcript and protein levels. The viability of HTFs was determined by cell counting kit-8 (CCK-8). FCM was used to assess cell cycle after CTGF-siRNA transfection. Results . The expression of CTGF and proliferation of HTFs were increased significantly by TGF- β 2 stimulation. The transfection of CTGF-siRNA abolished the upregulation of CTGF and cell proliferation induced by TGF- β 2 . The analysis of cell cycle indicated that CTGF-siRNA treatment stimulated cells from S phase to G0/G1 phase in comparison with the inverse physiologic function of TGF- β 2 . Conclusion . CTGF targeting siRNA could effectively suppress the expression of CTGF and attenuate the proliferation of HTFs. The siRNA approach may provide a therapeutic option for eliminating filtration bleb scarring after glaucoma filtration surgery (GFS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom